Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.20 +0.26 (+1.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Equity Income (2022 - 2024)

Updated

Amphastar Pharmaceuticals (AMPH) recorded Equity Income of -$573,000 in FY2024, compared with -$1.98 million in FY2023.

Analysis

Amphastar Pharmaceuticals (AMPH) Equity Income (2022 - 2024) Analysis & Trends

Starting with FY2021, Amphastar Pharmaceuticals' Equity Income history includes 4 years.

  • The FY2024 figure is the highest annual Equity Income since FY2021.
  • Per Business Quant data, AMPH's Equity Income was -$1.98 million in FY2023, -$1.18 million in FY2022 and -$208,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -10.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Amphastar Pharmaceuticals 1.15 Bn 6.74 Mn 93.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -573,000.00
Dec 31, 2023 -505,000.00
Sep 30, 2023 -390,000.00
Jun 30, 2023 -301,000.00
Mar 31, 2023 -785,000.00
Dec 31, 2022 -57,000.00
Sep 30, 2022 -163,000.00
Jun 30, 2022 -254,000.00
Mar 31, 2022 -703,000.00
API Access

Amphastar Pharmaceuticals Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=AMPH&period=max&api_key=YOUR_API_KEY